SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention

Coronary Artery Disease

Volumn 24, Issue 2, 2013, Pages 148-153

  Şahin, Durmuş Y ^a   Gür, Mustafa ^a   Elbasan, Zafer ^a   Kuloǧlu, Osman ^a   Şeker, Taner ^a   Kivrak, Ali ^a   Tanboǧa, Ibrahim H ^b   Gözübüyük, Gökhan ^a   Kirim, Sinan ^a   Çayli, Murat ^a  

^a Numune Training and Research Hospital   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

Author keywords

myocardial infarction; no reflow phenomenon; SYNTAX score

Indexed keywords

ADULT; AGED; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; BLOOD CLOT LYSIS; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYNTAX SCORE; THROMBUS;

AGE FACTORS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CORONARY THROMBOSIS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84873362762     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32835c4719     Document Type: Article

References (33)

1. Brodie BR, Stuckey TD, Hansen C, Muncy D. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol 2000; 85:13-18 (Pubitemid 30045537)
2. Stone GW, Cox D, Garcia E, Brodie BR, Morice MC, Griffin J, et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: Analysis from the primary angioplasty in myocardial infarction trials. Circulation 2001; 104:636-641 (Pubitemid 32738515)
3. Kloner RA, Ganote CE, Jennings RB. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974; 54:1496-1508
4. Laster SB, O'Keefe JH Jr, Gibbons RJ. Incidence and importance of thrombolysis in myocardial infarction grade 3 flow after primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1996; 78:623-626 (Pubitemid 126658613)
5. Feldman LJ, Himbert D, Juliard JM, Karrillon GJ, Benamer H, Aubry P, et al. Reperfusion syndrome: Relationship of coronary blood flow reserve to left ventricular function and infarct size. J Am Coll Cardiol 2000; 35:1162-1169 (Pubitemid 30206890)
6. Anderson JL, Karagounis LA, Becker LC, Sorensen SG, Menlove RL. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study. Circulation 1993; 87:1829-1839
7. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, et al. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation 1996; 93:879-888 (Pubitemid 26074824)
8. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000; 36:1202-1209
9. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996; 93:223-228 (Pubitemid 26031478)
10. Ndrepepa G, Tiroch K, Fusaro M, Keta D, Seyfarth M, Byrne RA, et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 2010; 55:2383-2389
11. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, et al. The SYNTAX score: An angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1:219-227
12. Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C, Tamburino C. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv 2009; 2:302-308
13. Capodanno D, Capranzano P, Di Salvo ME, Caggegi A, Tomasello D, Cincotta G, et al. Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft. JACC Cardiovasc Interv 2009; 2:731-738
14. Joint European Society of Cardiology/American College of Cardiology. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21:1502-1513
15. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit: A two year experience of 250 patients. Am J Cardiol 1967; 20:457-464
16. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by twodimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two- Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367
17. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985; 312:932-936
18. Gibson CM, de Lemos JA, Murphy SA, Marble SJ, McCabe CH, Cannon CP, et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: A TIMI 14 substudy. Circulation 2001; 103:2550-2554 (Pubitemid 32521963)
19. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol 2009; 54:281-292
20. Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G, et al. Impact of microvascular dysfunction on left ventricular remodeling and long term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 2004; 109:1121-1126 (Pubitemid 38332616)
21. Galiuto L, Barchetta S, Paladini S, Lanza G, Rebuzzi AG, Marzilli M, et al. Functional and structural correlates of persistent ST elevation after acute myocardial infarction successfully treated by percutaneous coronary intervention. Heart 2007; 93:1376-1380 (Pubitemid 351480134)
22. Magro M, Nauta ST, Simsek C, Boersma E, van der Heide E, Regar E, et al. Usefulness of the SYNTAX score to predict 'no reflow' in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Cardiol 2012; 109:601-606
23. FearonWF, Shah M, Ng M, Brinton T,Wilson A, Tremmel JA, et al. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2008; 51:560-565
24. Herrmann J. Peri-procedural myocardial injury: 2005 update. Eur Heart J 2005; 26:2493-2519 (Pubitemid 41679359)
25. Demirbag R, Yilmaz R, Gur M, Kocyigit A, Celik H, Guzel S, et al. Lymphocyte DNA damage in patients with acute coronary syndrome and its relationship with severity of acute coronary syndrome. Mutat Res 2005; 578:298-307 (Pubitemid 41395333)
26. Reilly MP, Delanty N, Roy L, Rokach J, Callaghan PO, Crean P, et al. Increased formation of the isoprostanes IPF2 alpha-I and 8-epiprostaglandin F2 alpha in acute coronary angioplasty: Evidence for oxidant stress during coronary reperfusion in humans. Circulation 1997; 96:3314-3320 (Pubitemid 27513400)
27. Hempel SL, Wessels DA, Spector AA. Effect of glutathione on endothelial prostacyclin synthesis after anoxia. Am J Physiol 1993; 264:1448-1457
28. Uyarel H, Cam N, Okmen E, Kasikcioglu H, Tartan Z, Akgul O, et al. Level of Selvester QRS score is predictive of ST-segment resolution and 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention. Am Heart J 2006; 151:e1-e7
29. Iwakura K, Ito H, Kawano S, Shintani Y, Yamamoto K, Kato A, et al. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol 2001; 38:472-477 (Pubitemid 32721776)
30. Skyschally A, Leineweber K, Gres P, Haude M, Erbel R, Heusch G. Coronary microembolization. Basic Res Cardiol 2006; 101:373-382 (Pubitemid 44275870)
31. Hori M, Inoue M, Kitakaze M, Koretsune Y, Iwai K, Tamai J, et al. Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am J Physiol 1986; 250:H509-H518
32. Limbruno U, De Carlo M, Pistolesi S, Micheli A, Petronio AS, Camacci T, et al. Distal embolization during primary angioplasty: Histopathologic features and predictability. Am Heart J 2005; 150:102-108 (Pubitemid 41097435)
33. Thiele H, Schindler K, Friedenberger J, Eitel I, Fürnau G, Grebe E, et al. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: The randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation 2008; 118:49-57.